The PRCTRC Technologies and Resources for Core Laboratories function provides a network of laboratory resources to support clinical and translational science in Puerto Rico. It provides access to expertise and instrumentation in available technologies for clinical and translational investigators. The following site contains information about the Bioanalytical Core Lab at the PRCTRC (MSC-UPR), Genomic Translational Research Unit (MSC-UPR), PHSU and UCC Services and Equipment Units.

  • Provide and develop training opportunities in emerging methodologies that are relevant to the clinical and translational investigators, technical and support staff.
  • Expand and maintain collaborations with public, private, and government organizations to increase access to additional research resources for clinical and translational investigators addressing health disparities.
  • Coordinate and provide continuous access of clinical and translational research laboratory services among PRCTRC.
  • Maintain and expand the Genomic Translational Research Unit.
  • In collaboration with PDC, provide training opportunities focusing on creating expertise in new and emerging technologies.
  • Establish the Research Training Opportunity Program (RTOP) to support emerging and innovative technologies.
  • In collaboration with CPC, maintain and expand the TRCL Network in Puerto Rico.
  • In collaboration with CPC and CBR, seek to make new alliances with core facility directors in Puerto Rico and elsewhere to provide greater access to research resources among PRCTRC investigators.
  • Collaborate with AC to implement the new charge-back policy to recover a percentage of the cost invested in federally funded studies.

Core Accomplishments:

  • Developed training opportunities in emerging methodologies that are relevant to the clinical and translational investigators, technical and support staff.
  • Establish the Research Training Opportunity Program (RTOP). Four investigators affiliated to PRCTRC institutions have been supported.
  • Provides technical expertise, instrumentation, and services, while prioritizing investigator access to TRCL facilities and services according to the research area, translational potential, and clinical application of the project.
  • Establish the cost recovery system among clinical and translational research supported by TRCL in collaboration with the Administrative Core.
  • Support the development of the Puerto Rico Omic Center (PROMIC).
  • 224 studies have been supported by TRCL.
  • 97 investigators and faculty have been supported by TRCL.
  • 29 grants were awarded by TRCL users, for a total of $9,970,804.


YearStudies SupportedInvestigators SupportedPeer-Reviewed PublicationsGrants Applications SubmittedGrants Funded


Our Services

Approval DateStatusPI Last NamePI NameShort TitleTitlePI InstitutionTRCL MSCTRCL UCCTRCL PHSU 
July 2, 2018OpenVila-PerezLuis M.PROFILE4Characterization of the lupus nephritis miRNAnome (PROFILE 4)UPR-MSCYesNoNo
April 3, 2019OpenRamos-CortesEdwardoDMDATA Phase 3, Randomized, Double Blind, Placebo- Controlled Efficacy and Safety Study of Ataluren in Patients with Nonsense Mutation Duchene Muscular Dystrophy and Open-Label ExtensionUPR-MSCYesNoNo
December 3, 2018OpenSantiagoDarlenePKBUPPharmacokinetics and patients perceived effectiveness of Suboxone buccal films in Puerto Rican patients: A Descriptive StudyUPR-MSCYesNoNo
June 3, 2019OpenMendezKeimarieHPV303Reveal 2: A Prospective, Randomized, Double-Blind, Placebo Controlled Phase 3 Study of VGX-3100 Delivered Intramuscular Followed by Electroporation with Cellectra 5PSP for the Treatment of HPV-16 and /or HPV-18 related high grade Squamous intraepithelial lesion (HSIL) on the cervical (HPV-303)UPR-MSCYesNoNo
April 5, 2015OpenGuiot-MartinezHumbertoAMC #072Protective Effect of Quadrivalent Vaccine in Young HIV-positive Males Who Have Sex with MalesUPR-MSCYesNoNo
August 5, 2019OpenCampos-RiveraMaribelRM493023A Phase 3 trial of Setmelanotide (RM493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alstrom syndrome (AS) Patients with Moderate to Severe ObesityUPR-MSCYesNoNo
July 5, 2018OpenOrtiz-Martinez de AndinoAna P.AOMHCross-sectional Association of Oral Microbiota with Oral HPV Infections among High-risk Hispanics adultsUPR-MSCYesNoNo
November 5, 2018OpenMorouEvangeliaHELIOSEpigenetic and Microbial profiles related to Hurricane Maria prenatal stressors (HELiOS)UPR-MSCYesNoNo
February 6, 2017OpenAndriankajaOelisoa M.LLIPDSLipid Lowering Agents use in Periodontitis and Diabetes Study (LLIPDS)UPR-MSCYesNoNo
February 6, 2018OpenBurgos-CalderonRafaelCARDINALA Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport SyndromeUPR-MSCYesNoNo
March 7, 2018OpenNazario-JimenezSylvettePREPAREPatient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted PopulationsUPR-MSCYesNoNo
September 7, 2012OpenBuxo-MartinezCarmen J.FACES GENESOral Clefts Malformations in Puerto Rican Children: Genetic Risk Factors and Maternal ExposuresUPR-MSCYesNoNo
August 8, 2018OpenCruz-CorreaMarcia R.DFAPPhase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous PolyposisUPR-MSCYesNoNo
December 8, 2015OpenCaninoGlorisaChildhood CardiovascularChildhood Adversity and Cardiovvascular Health among Puerto Rican YouthUPR-MSCYesNoNo
February 8, 2019OpenCruz-CorreaMarcia R.POLYNWU2016-08-02 A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels inpatients with cirrhosisUPR-MSCYesNoYes
May 8, 2017OpenCruz-CorreaMarcia R.HVACMAY2013-02-01 Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) InfectionUPR-MSCYesNoNo
February 11, 2014OpenEstape-GarrastazuEstela S.CARDIOTONIC-2Assessment of Cardiotonic Steroids in Ischemic Stroke PatientsUPR-MSCYesNoNo
January 11, 2017OpenGuiot-MartinezHumbertoAMC-088A Randomized phase III study of intra-anal Imiquimod 2.5% vs Tropical-5 fluorouracil 5% vs Observation for the treatment of high-grade anal squamous intra epithelial lesions in HIV-infected men and womenUPR-MSCYesNoNo
July 11, 2014OpenCruz-CorreaMarcia R.MUC1 VACCINERandomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients with Newly Diagnosed Advanced AdenomasUPR-MSCYesNoNo
May 11, 2018OpenSerrano-RamosCarmenPRESENCEEffect of LY3154207 on Cognition in Mild-to-Moderate Parkinson's Disease Dementia (PPD)UPR-MSCYesNoNo
April 12, 2018OpenCampos-RiveraMaribelDCEZDental and Craniofacial Effects of Intrauterine Zika infectionUPR-MSCYesNoNo
December 12, 2016OpenCampos-RiveraMaribelPerinatal SSProspective Assessment of Intrauterine Zika Exposure: An Integrated ApproachUPR-MSCYesNoNo
November 12, 2015OpenTirado-GomezMaribelANCHORANCHOR: Anal Cancer Prevention StudyUPR-MSCYesNoNo
January 13, 2006OpenJimenez-VelazquezIvonne Z.ALZHEIMER/EFIGARisk Factors for Alzheimer's Disease and Related Disorders in the Caribbean Hispanic Population of Puerto RicoUPR-MSCYesNoNo
June 13, 2017OpenCruz-CorreaMarcia R.DFMOTargeted chemoprevention of gastric carcinogenesis in high risk populationsUPR-MSCYesNoNo
June 13, 2018OpenDiaz-PerezClementeZIK101ZIK-101: A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Safety, Immunogenicity, and Dose Ranging Study of Purified Inactivated Zika Virus Vaccine (PIZV) Candidate in Flavivirus Naive and Primed Healthy Adults Aged 18 to 49 YearsUPR-MSCYesNoNo
October 13, 2015OpenWojna-MunizValerieSIR-HANDExosome-mediated soluble insulin receptor secretion correlates with HANDUPR-MSCYesNoNo
14dic2016OpenDe Jesus-GonzalezNilkaGWASGenome Wide ASsociation Study of Childhood Onset Idiopathic Nephrotic SyndromeUPR-MSCYesNoNo
February 14, 2019OpenJoshipuraKaumudiSOALSPREPAREPreparedness to Reduce Exposures and diseases Post-hurricanes & Augment ResilienceUPR-MSCYesNoNo
November 15, 2012OpenRodriguez-RiveraZoe M.SMARTT STUDYSurveillance Monitoring for ART Toxicities Study in HIV unifected Children Born HIV-infected Women (SMARTT Study PH 100)UPR-MSCYesNoNo
August 18, 2014OpenJimenez-VelazquezIvonne Z.DIAN-TU-001A Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's DiseaseUPR-MSCYesNoNo
January 18, 2019OpenCruz-CorreaMarcia R.GENETICA MOLECULAREstudios de genetica molecular para pacientes con cancerUPR-MSCYesNoNo
January 18, 2019OpenJimenez-VelazquezIvonne Z.GRADUATEA Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Study of Gantenerumab in Patients with Early (Prodromal to mild) Alzheimer's DiseaseUPR-MSCYesNoNo
August 19, 2014OpenTirado-GomezMaribelAMC-084Screening HIV Infected Women for Anal Cancer PrecursorsUPR-MSCYesNoNo
May 19, 2017OpenRomaguera-AgraitJosefina E.HPV301A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 delivered Intramuscularly followed by Electroporation with Cellectra 5PSP for the Treatment of HPV-16 and/or HPV-18 related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix (Version 3.0 23 Sep 2016)UPR-MSCYesNoNo
June 20, 2017OpenMiquelajaureguiAmayaBASDevelopmental characteristics of brain activity signals in infants at high risk of autism spectrum disorder (ASD) in Puerto RicoUPR-MSCYesNoNo
November 20, 2015OpenMartinezIdaliCHIKV-PPIdentification of biomarker of chronic arthralgia after Chikungunya infectionUPR-MSCYesNoNo
March 21, 2019OpenBurgos-CalderonRafaelGPGMEfficacy and Safety of LY3298176 Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS--4)UPR-MSCYesNoNo
December 22, 2017OpenRomaguera-AgraitJosefina E.M14702A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethinfrome Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain (M14-702)UPR-MSCYesNoNo
July 23, 2019OpenCruz-CorreaMarcia R.STATINSStatin Therapy to Reduce Disease Progression from Liver Cirrhosis to CancerUPR-MSCYesNoNo
April 24, 2017OpenCruz-CorreaMarcia R.GASTRICCURCUMINMAY2015-05-01 Randomized, double-blind, placebo-controlled trial of Meriva (curcumin) as a candidate chemoprevention agent for gastric carcinogenesisUPR-MSCYesNoNo
April 24, 2018OpenCaninoGlorisaSTARStress and Treatment Response in Puerto Rican Children with AsthmaUPR-MSCYesNoNo
August 25, 2014OpenGonzalez-MercadoVeldaGENE EXPRESSIONAssociation between Differential Gene Expression and Fatigue Symptoms of Puerto Rican patients during Cancer TreatmentsUPR-MSCYesNoNo
January 27, 2017OpenCampos-RiveraMaribelBABY-ACT TRIALIntervention to promote physical activation and improve sleep and feeding practices in infants for preventing obesity early in life (The Baby-Act Trial)UPR-MSCYesNoNo
April 28, 2016OpenTorresEsther A.IBD-HPSGenotypic and phenotypic manifestations and disease progression in Puerto Ricans with Inflammatory Bowel Disease and Hermansky-Pudlak SyndromeUPR-MSCYesNoNo
March 28, 2018OpenRomaguera-AgraitJosefina E.M16283A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women (M16-283)UPR-MSCYesNoNo
January 31, 2019OpenRalat-RiveraSandra I.ICNBInflammatory cytokines and neurocognitive functioning in Bipolar Disorder across mood episodesUPR-MSCYesNoNo
April 2, 2014OpenNazario-DelgadoCruz M.ECHORNRed para la investigacion de salud en el Caribe Oriental-ECHORNUPR-MSCYesNoNo
September 15, 2010OpenFernandezDiana M.RRCLCRetrovirus Research Center Leadership CoreuccNoYesNo
March 25, 2015OpenAlvesJanaina M.LIFUtility of LIF to protect against HIV-1 associated neurocognitive disordersuccNoYesNo
June 4, 2018OpenArmaiz-PenaGuillermo N.IROCAdrenergic Modulation of Inflammatory Resposes in Ovarian CancerphsuNoNoYes
September 8, 2016OpenRivera-AmillVanessaMicrobiomeHDThe microbiome in the setting of HIV infection and DepressionphsuNoNoYes
September 8, 2016OpenRivera-AmillVanessaMS-AR-MSMMetabolic syndrome and prophylactic anti-retrovirals in men who have sex with menphsuNoNoYes
June 13, 2018OpenDutilJulieIL12BCThe role of the IL-12/STAT 4 axis in the context of breast cancerphsuNoNoYes
October 18, 2017OpenFloresIdhalizHTTHistone modifications as a potential diagnostic and therapeutic target on EndometriosisphsuNoNoYes
October 19, 2017OpenSantiago-CardonaPedroMETARBPA Rb phophorylation code associated with metastasisphsuNoNoYes
August 25, 2017OpenSuarezEduPAR2PAR-2 Variants: A Step Forward to Individualized Medicine in AsthmaphsuNoNoYes
September 27, 2016OpenAppleyardCarolineBGFloraTargeting of the Brain-gut-flora axis using probiotics in endometriosisphsuNoNoYes
May 29, 2019OpenFloresIdhalizMTTEHistone methylation as a therapeutic target in endometriosisphsuNoNoYes
November 30, 2017OpenNoelRichardMGCLABMolecular and Genomics Core Laboratory RCMIphsuNoNoYes
November 30, 2017OpenIsazaClaraPDMEstablish of an in-vitro Parkinsons Disease modelphsuYesNoYes
August 31, 2018OpenSaavedraHarold I.E2FBCRole of E2Fs Activators and Mitotic Kinases Regulated by E2Fs in Breast Cancer EMT, Invasion, and MetastasisphsuNoNoYes
January 31, 2018OpenSabateNuriaPTSDCHILDRENClinical prevalence and biological correlates of PTSD in children and adolescents in southwest Puerto RicophsuNoNoYes

(Back) Carola Lopez-Cepero Román, Denisse Melecio, Nilda González
(Front) José Rodríguez-Medina



  • Vitros 250 (Routine Chemistry)
  • Hood
  • Microscope
  • Incubators
  • Refrigerators
  • Freezers
  • Water Baths
  • Clinitek 500 (Urinalysis)
  • DCA 2000+ (HbA1c and Microalbumin)
  • Refrigerated Centrifuges
  • Micro-centrifuge
  • AcT 5diff CP (Hematology)


  • Centrifuge
  • Prepare slides
  • Storage (room temperature, refrigerated, frozen)
  • Packing
  • Shipping (room temperature, dry ice)
  • Preservation of samples (with diluents, buffers, etc.)
  • Process serum samples for Comprehensive Metabolic Panel
  • Process serum samples for Basic Metabolic Panel
  • Process serum samples for Lipid Panel
  • Process whole blood samples for HbA1c
  • Process whole blood samples for CBC (Complete Blood Count) and 5-part Differential
  • Process urine samples for Urinalysis
  • Process urine samples for Microalbumin
  • Process urine samples for Pregnancy Test

Lab Technician

The PRCTRC Genomic Translational Research Unit is housed in the second floor of the UPR-MSC main building, Rm. A231A (~250 square foot laboratory). The target faculty are investigators conducting genomics research at University Pediatric Hospital Newborn Screening Program, basic and clinical faculty conducting research in cancer diagnostics and cancer treatment at the UPR Comprehensive Cancer Center (UPRCCC), and UPR-MSC faculty conducting fundamental research in genomics, genetics and pharmacogenomics. Translational researchers working with model systems who have established collaborations with clinical faculty are also welcome.


  • DNA extraction and QC
  • RNA extraction, cDNA template preparation, and QC
  • Library Preparation for Sequencing, Templates preparation
  • DNA Sequencing Reactions (type of service: whole genome, whole exome, transcriptome (RNAseq), ChIPSeq, other)
  • Processing of raw data for subsequent bioinformatics analyses by investigator


  • DNA extraction and QC
  • RNA extraction, cDNA template preparation, and QC
  • Library Preparation for Sequencing, Templates preparation
  • DNA Sequencing Reactions (type of service: whole genome, whole exome, transcriptome (RNAseq), ChIPSeq, other)
  • Processing of raw data for subsequent bioinformatics analyses by investigator


  • Gel and Blot Imaging Systems
  • Typhoon 7000 FLA, GE
  • Epi Chemi II Darkroom, UVP
  • Thermal Cycler and Q-PCR Systems
  • DNA Engine, BIO-RAD
  • DNA Engine DYAD, MJ Research
  • iCycler, BIO-RAD
  • Realplex2, Eppendorf
  • Eco, Illumina
  • Nucleic Acid and Protein
  • Quantification and Analysis
  • Biophotometer, Eppendorf
  • NanoDrop 2000, Thermo Sci.
  • Experion, BIO-RAD
  • Microscope and Cell Analysis
  • Cellometer K2, Nexcelom
  • Evos Fl, Life Technologies
  • BX60 microscope, Olympus
  • Multimode Plate Reader
  • Synergy HT, BioTek
  • Tissue and Sample Dissociators
  • gentleMACS Disruptor, Miltenyi
  • Bullet Blender Storm, Next Advance
  • Sonicator, Fisher
  • Development of animal models for human diseases
  • Histology tissue in paraffin embedding
  • Histo Core


  • Tissue Culture
  • Transfection/Transformation
  • DNA, RNA and Protein Isolation
  • Cell Cryostorage
  • Expertise/consultation in experimental design using molecular biology


  • FACSCanto II
  • Class II Safety Cabinets
  • Refrigerators
  • Thermocycles
  • Repository for Lymphocytes and Plasma
  • Centrifuges
  • CO2-incubators


The HIV and Substance of Abuse Laboratory Core (H-SALC) provides technical service needed to support studies in the areas of HIV/AIDS and related diseases.

  • Ultrafreezers
  • iCycler iQ Real-Time PCR
  • Elispot

Standard Operation Procedures

Dr. Pedro Santiago-Cardona (PHSU)
Co-Program Director
787-840-2575, ext. 2200 ó 2248

Camille M. Chardón Colón (PHSU), MS
Research Laboratory Technician
Tel: 787.840.2575 x2200

Elaine Camacho
Research Laboratory Technician
Tel: 787.840.2575 x2200

Dr. Misty Eaton (UCC)
Key Function Co-Leader
787 798-3001 ext. 2034

Dr. José Rodríguez Medina (MSC)
Key Function Leader -RCM
758-2525 ext 2299

Nilda L. González Hernández, Ms, MT(ASCP)  (MSC)
Core Laboratory Manager
787-759-0306 ext 226

Carola M. López-Cepero Román, Ms, MT (ASCP) (MSC)
Medical Technologist II
787-759-0306 ext 226
carola.lopez-cepero@upr. edu

Denisse Melecio Alamo (MSC)
Core Coordinator